Clinical Trials Logo

Filter by:
NCT ID: NCT05040165 Completed - Prosthesis Failure Clinical Trials

Investigation on Failure Time Analysis of a New TPE Material in the Iceform Liner

Start date: December 8, 2019
Phase: N/A
Study type: Interventional

Durability evaluation of a new material blend in the Iceform liner and Iceform sleeve.

NCT ID: NCT05040152 Completed - Clinical trials for Obesity-Related Malignant Neoplasm

Weight Loss Intervention for the Reduction of Cancer Risk and Health Disparities in Rural Ohio

HERO
Start date: November 6, 2021
Phase: N/A
Study type: Interventional

This study determines the feasibility of a telephone-based weight lost intervention in reducing cancer risk and health disparities in rural Ohio. Obesity is the leading preventable cause of cancer, and obesity-related inflammation is linked to elevated cancer risk, independent of obesity itself. Rural populations are a vulnerable population in need of increased access to tailored strategies and benefit from weight loss interventions. This study aims to see whether a telephone-based intervention may help obese people in rural area to reduce body weight, so as to prevent obesity-related cancer.

NCT ID: NCT05040100 Completed - Clinical trials for Anatomy Teaching Methods

Utilizing a 3D Printed Model of the Mediastinum to Teach Thoracic Anatomy to Medical Trainees

Start date: September 4, 2019
Phase: N/A
Study type: Interventional

Three-dimensional (3D) printed anatomic models are increasingly being developed for medical education. The investigators sought to compare the efficacy of a 3D printed model of the mediastinum as a study tool with standard textbooks for teaching medical trainees thoracic anatomy. Participants were randomly assigned to either a lecture using a standard anatomy textbook or the same lecture along with a 3D printed model of the mediastinum. Participants took a timed pre-test and post-test, identifying 12 mediastinal structures on a prosected human cadaver. Independent and dependent t-tests were used to compare individual and group improvements respectively. A subjective assessment was also performed.

NCT ID: NCT05040061 Completed - Clinical trials for Generalized Anxiety Disorder

SkillJoy Clinical Trial

SkillJoy
Start date: May 17, 2018
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial comparing a smartphone-delivered savoring intervention (SkillJoy) for Generalized Anxiety Disorder to an active treatment control.

NCT ID: NCT05039970 Completed - Diabetes Mellitus Clinical Trials

A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program

Start date: September 7, 2021
Phase: N/A
Study type: Interventional

The overall prevalence of type 2 diabetes in the United States (US) is estimated at more than 30 million people, with an estimated 88 million more adults meeting the criteria for having prediabetes and being at risk for progressing to type 2 diabetes. The significant burden of diabetes, as well as the high individual and societal cost it bears, renders this disease among the highest public health priorities for the health authorities and policy makers. In response to the rising diabetes prevalence, the US Centers for Disease Control and Prevention (CDC) established the National Diabetes Prevention Program (National DPP) in 2010 as a framework for diabetes prevention by providing evidence-based, affordable, and high-quality lifestyle change programs (LCPs). The National DPP LCP is a yearlong education-based curriculum focused on achieving modest weight loss (5% to 7%) and increasing participants' physical activity to reduce the risk of progressing to type 2 diabetes. To ensure high-quality programs and meaningful impact on participants, the CDC sets standards for organizations that wish to offer an LCP through the Diabetes Prevention Recognition Program (DPRP). The DPRP plays a critical role in ensuring that organizations can effectively deliver the evidence-based lifestyle change program with quality and fidelity. To achieve recognition status, organizations must periodically provide evidence that they are following a CDC-approved curriculum and achieving meaningful results on session attendance, body weight change, and physical activity minutes. A recent analysis of National DPP data has shown that the attrition rates in this program are substantial and that they differ by age and race. Moreover, the attrition rates were inversely associated with the program success, as reflected by the LCP outcomes, and, specifically, participants' weight and level of physical activity. In view of these findings, the CDC is undertaking an effort to increase participant retention in the National DPP. The proposed study will evaluate the pilot use of a free-of-charge mobile device-based serious health game (WellQuestâ„¢) within the frame of the National DPP LCP. WellQuestâ„¢ was designed with the goals to improve participant engagement and retention in the LCP, to encourage adoption and maintenance of healthy lifestyle habits among LCP participants, and to reinforce knowledge of the LCP curriculum.

NCT ID: NCT05039723 Completed - Photoaging Clinical Trials

Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational

Start date: September 1, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the improvement in signs of photoaging and subject satisfaction after combination, global facial and/or neck treatment with IncobotulinumA (Xeomin), HA (Belotero) and/or calcium hydroxyapatite (Radiesse+, Radiesse Classic). All products will be used on-label FDA-cleared indications.

NCT ID: NCT05039671 Completed - Clinical trials for School-based Mental Health Treatment Services

Feedback and Outcomes for Clinically Useful Student Services (FOCUSS)

Start date: August 17, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the implementation outcomes (i.e., feasibility, appropriateness, acceptability, and fidelity) of MBC in school-based mental health treatment services. The investigators plan to observe the effectiveness of MBC on student engagement and treatment outcomes as a secondary goal. This pilot implementation-effectiveness trial is designed to inform a future, large-scale trial with more participants.

NCT ID: NCT05039541 Completed - Clinical trials for Dialysis Access Malfunction

The ReModel IHC Study for ESRD Patients

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

There will be two phases of this study. The phases of this study may occur simultaneously. In Phase I, eligible subjects will be asked to acutely wear the Alio Medical RMS SmartPatch during regularly scheduled dialysis sessions. Subjects will have a pre- and post-dialysis blood draw(s), vitals collected, and monitoring throughout the dialysis sessions. The SmartPatch will be removed from the location(s) where it is placed following the post-dialysis blood draw. In Phase II, subjects will be asked to wear a SmartPatch for up to 90 days. Subjects will be trained on the use of the Alio Medical RMS and be provided a system for them to utilize at home. Patches will be changed at a minimum of once every 7 days.

NCT ID: NCT05039528 Completed - Clinical trials for Obstructive Sleep Apnea

Design and Usability Testing of a Tailored Intervention About Sleep and Sleep Disorders Among Transportation Workers

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The objective of this protocol is to conduct a focus group to identify OSA beliefs, attitudes, and knowledge among employees in the transportation industry on shift schedules.

NCT ID: NCT05039476 Completed - Aging Clinical Trials

Study to Identify if Chemist Confessions Retinol Cream Works to Improve the Appearance of Early Signs of Aging.

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Chemist Confessions has developed a retinol cream with the aim to improve the appearance of early signs of aging, such as fine lines, dark spots, hyperpigmentation, and crow's feet. In this phase, Chemist Confessions plans to collect self-reported outcomes and photographic images to understand the assessment of the efficacy of treatment from the participant's perspective, and if participants see an improvement in their fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet.